Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2026)

Maravai Lifesciences Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 18.93% year-over-year to $40.5 million in Q1 2026; TTM through Mar 2026 was $40.5 million, a 18.93% decrease from a year earlier, with the FY2025 full-year figure at $45.3 million, down 10.74% from the prior year.
• Inventory Average retreated to $40.5 million in Q1 2026 per MRVI's latest filing, from $42.9 million in the prior quarter.
• Across five years, Inventory Average topped out at $61.3 million in Q3 2022 and bottomed at $40.5 million in Q1 2026.
• The 5-year median for Inventory Average is $49.9 million (2024), against an average of $49.9 million.
• Across the five-year window, Inventory Average climbed 28.02% in 2022 and retreated 21.21% in 2023, its largest moves.
• Year by year, Inventory Average stood at $52.8 million in 2022, then decreased by 4.77% to $50.3 million in 2023, then rose by 0.08% to $50.3 million in 2024, then dropped by 14.7% to $42.9 million in 2025, then dropped by 5.67% to $40.5 million in 2026.
• Per Business Quant, the three latest MRVI Inventory Average figures stand at $40.5 million (Q1 2026), $42.9 million (Q4 2025), and $46.0 million (Q3 2025).